Objectives Our purpose was to evaluate the appropriateness of multidetector computed tomography angiography (MDCTA) as an anatomical standard for decision making in patients with known or suspected coronary artery disease.
Visual estimation of coronary stenosis severity during invasive coronary angiography (CA) does not predict its hemodynamic significance, even when performed and analyzed by experienced cardiologists (1, 2) . Yet coronary revascularization using stented angioplasty is triggered off increasingly often by anatomical imaging (3, 4) . This trend is likely to increase with the availability of noninvasive multidetector computed tomography coronary angiography (MDCTA). Although correlative studies between MDCTA and CA show good agreement (5, 6) , MDCTA visualizes plaque burden and calcifications well before luminal dimensions are encroached (7) (8) (9) . As a result, the information content of MDCTA is broader than that provided by CA, which may improve the decision whether or not to proceed with revascularization.
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The purpose of this prospective study was: 1) to compare the assessment of coronary stenosis severity by MDCTA versus invasive angiography in patients with known or suspected coronary artery disease (CAD); and 2) to evaluate the appropriateness of using MDCTA as the anatomical substrate for clinical decision making with respect to revascularization. Appropriateness of revascularization was assessed by pressurederived fractional flow reserve (FFR), a reliable invasive index of stenosis hemodynamic significance. FFR expresses the maximum achievable blood flow to the myocardium supplied by a stenotic artery as a fraction of normal maximum flow (10, 11 ). An abnormal value Յ0.75 identifies stenosis that is associated with inducible ischemia (12, 13 ) that can be relieved by stented angioplasty or bypass grafting. Operators were encouraged to base the treatment strategy on FFR results, but final individual decisions were taken on the basis of all available data, at their discretion.
Methods
Patient selection. The study population consisted of 88 patients in whom MDCTA was implemented in the diagnostic workup of chest pain, of which 7 patients were excluded because of uninterpretable or technically poor MDCTA studies. From the remaining 81 patients, 39 had stable angina (48%) and 42 (52%) had atypical chest pain. Selected patients were identified prospectively at the time of their first visit at the outpatient clinic. Exclusion criteria were as follows: atrial fibrillation, creatinine clearance below 30 ml/min, and allergy to iodinated contrast agents. Only 15 patients (19%) were known to have CAD from prior history. In the 61 (81%) patients with suspected CAD, the pre-test probability for obstructive CAD was calculated using the Duke clinical risk score, which includes type of chest pain, age, sex, and traditional risk factors (14, 15) . Subjects are classified as low, intermediate, or high risk. Conventional CA was performed according to local practice 26 Ϯ 11 days after the MDCTA. Follow-up was performed to evaluate the clinical event rates: new revascularization after the index procedure, new angina onset, myocardial infarction, and cardiac death. The study protocol was approved by the institutional ethics committee and patients gave informed consent for participation and data collection. CA and FFR assessment. Distal coronary pressure measurement was performed with a 0.014-inch pressure guidewire (Radi Medical Systems, Uppsala, Sweden). The wire was introduced through a 6-F guiding catheter, calibrated, advanced into the coronary artery, and positioned in the distal vessel beyond the stenosis as previously described (11) . Adenosine was administered to induce maximum hyperemia, either intravenously (140 g/kg/min) or intracoronary (at least 15 g in the right or 20 g in the left coronary artery) (11, 16, 17) . FFR was calculated as the ratio of mean hyperemic distal coronary pressure measured by the pressure wire to mean aortic pressure measured by the guiding catheter. The measurement was performed twice, and FFR was taken as the average of both measurements. Interrogated coronary vessels (n ϭ 116) were segmented according to the American Heart Association classification (18 bolus (on average 90 ml at 5 ml/s) of contrast material (iomeprol, 816.5 mg/ml [Iomeron 400, Bracco Altana Pharma, Konztanz, Germany]) was injected intravenously followed by a 50-ml saline flush. After a scan delay, the scan started automatically when the density in the aortic root reached a density value of 100 HU. All the datasets were evaluated offline on an image analysis workstation (TeraRecon Inc., San Mateo, California). MDCTA data were evaluated on axial plane source images, on curved multiplanar reconstruction, and on different maximal intensity projections. Coronary vessel segmentation was matched with CA, and stenosis severity was graded as described in the preceding text by independent experienced observers unaware of grading results on CA. Statistical analysis. The diagnostic performance of MDCTA and CA for the detection of functionally significant CAD as defined by FFR Յ0.75 is presented as sensitivity, specificity, positive and negative predictive values with the corresponding confidence intervals, and positive and negative likelihood ratios. Comparisons between MDCTA and FFR or CA and FFR were performed for each interrogated vessel. Continuous variables are expressed as means and standard deviation. Differences in means among groups were analyzed by a 2-sided t test or by 1-way analysis of variance using a Tukey-Kramer test to compare all pairs. Categorical variables are expressed as absolute numbers and percentages. Interobserver and intraobserver variability of the score grading by MDCTA and CA and agreement between techniques were tested by kappa statistics. False negatives were defined as vessels with abnormal FFR but nonobstructive stenosis (grade 0 to 1). False positives were defined as vessels with normal FFR but obstructive stenosis (grade 2).
The proportion of patients with consistent or inconsistent treatment decisions that are in accordance with test results is shown as absolute number and percentage for each technique. Unpaired and paired comparison between proportions uses the chi-square and McNemar tests, respectively. Appropriateness by FFR refers to revascularization of hemodynamically significant stenoses and deferral of nonsignificant stenoses, meaning that appropriateness is based on treatment decisions that are in accordance with functional test results. Any other decision will be called inappropriate. Operators were encouraged to base the treatment strategy on FFR results, but final individual decisions were taken on the basis of all available data, at their discretion. Kaplan-Meier curves are comparing major adverse cardiac event rates between inappropriate/appropriate treatment guided by MDTCA and FFR, respectively. Comparison between the curves uses the Gehan-Breslow-Wilcoxon test.
Results
Patient demographics are shown in Table 1 . Obstructive CAD (grade 2) was diagnosed in 37 (44%) patients by CA AMI ϭ acute myocardial infarction; BMI ϭ body mass index; CA ϭ coronary angiography; HR ϭ heart rate; MVD ϭ multivessel disease; PCI ϭ percutaneous coronary intervention. Figure  5 . The event-free survival rate was significantly worse in the inappropriate versus the appropriate treatment group, as defined by FFR: 68 % versus 89%, respectively (p ϭ 0.02).
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Implications for selection of lesions for revascularization.
Given the weak correlation between FFR and both MDCTA and CA, indications for revascularization purely based on anatomy will be inappropriate by FFR guidance in nearly 30% of patients (Figs. 3 and 4) . Decision making based on MDCTA would result in revascularization in the absence of ischemia in 22% (18 of 81) and inappropriate deferral in 7% of cases (6 of 81). Decision making based on CA would result in revascularization in the absence of ischemia in 16% (13 of 81) and inappropriate deferral in 12% of cases (10 of 81). Decision making based on MDCTA will not result in significantly less revascularization in the absence of ischemia or inappropriate deferral than with CA. In patients inappropriately deferred by the operator despite abnormal FFR, reduced flow reserve was due to diffuse disease in nearly 40% of the cases, while focal stenosis eventually amenable to stented angioplasty was present in the remainder (Fig. 6 ).
Discussion
In patients with stable CAD, outcome-based trials (19) and guidelines (20) recommend revascularization in the presence of disabling symptoms or extensive stress-inducible ischemia. Although large cohort studies (21) have shown statistically significant correlations between stenosis severity assessed by quantitative CA and noninvasive or invasive functional testing, variability is such that one cannot rely on the coronary angiogram for clinical decision making in the individual patient. There are many reasons why the evaluation of stenosis severity may differ whether analyzed by CA or physiology. Selective CA does not account for the extent of downstream collateral supply or the size of the myocardial segment subtended by a given coronary artery. Diffuse luminal narrowing is common and precludes the selection of a "normal" reference segment (22) . Given the performance characteristics of the current 64-slice MDCTA, we hypothesized that this new coronary imaging modality would be more accurate than CA in identifying hemodynamically significant stenoses. Indeed, MDCTA is superior to CA by providing direct visualization of plaque load (23) . Opacification of the coronary lumen by intravenous contrast delivery accounts for all sources of blood supply. Tomographic imaging allows multiplanar reconstructions that render the tridimensional structure of the coronary arteries and provides a more accurate description of eccentric stenoses.
Yet the present study shows an equally poor diagnostic performance of both imaging techniques, MDCTA and CA, for the detection of functionally significant CAD. The 26% false positive rate with MDCTA was associated with increased calcium scores. Arterial wall calcifications can be present from the early stages of atherosclerosis (24) . The presence of calcifications causes blooming artifacts that increase plaque volume. With MDCTA, high coronary calcium load leads to stenosis overestimation and false positive results (25) . Clinical implications. Irrespective of mechanisms, this study demonstrates that indications for revascularization based solely on anatomy will be inappropriate in 21% (24 of 116) to 26% (30 of 116) of cases. As a matter of fact, the worst clinical outcome was seen in patients with inappropriate treatment according to FFR as a standard of reference. Because acute myocardial infarction and sudden death can proceed from plaque events at mildly obstructed sites, some physicians and patients fear to defer "treatment" of nonobstructive plaque, and preventive mechanical "plaque sealing" has been advocated. However, this hypothesis has not been properly investigated thus far (26, 27) . Instead, stented angioplasty of nonhemodynamically significant stenoses with an FFR Ͼ0.75 was shown not to improve the patient's prognosis or symptoms, while consuming resources unnecessarily (12, 13) . These results of the DEFER (Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis) study (13) were confirmed by the larger FAME (Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Interventions) trial (28) showing improved outcome with reduced costs in patients with multivessel disease randomized to FFR-guided stented an- gioplasty, as opposed to intervention guided by anatomy only. These data are consistent with the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial (19) of which a recently published substudy (29) indicates that revascularization improves outcome only when substantial ischemia is present before-and reduced by-revascularization. In the present clinically oriented study, revascularization decisions were left to the operator's discretion, which was in agreement with the results of anatomo-functional evaluation in 80% of cases (much higher than the 50% reported by Meijboom et al. [30] ). Noninvasive coronary imaging by MDCTA has been recommended as a screening tool for identification of patients to be referred for revascularization (31) . In accordance with recently issued guidelines (32), the present study invalidates any diagnostic strategy that would not incorporate functional testing for the presence of inducible ischemia, be it performed noninvasively before catheterization or during the invasive procedure using pressure-derived FFR (33) . Example of a false-negative stenosis, graded as nonobstructive (grade 1) both by multidetector computed tomography angiography (A) and coronary angiography (B) while fractional flow reserve (FFR) was significantly reduced (C). Decision making driven by anatomy will result in inappropriate deferral of revascularization. 
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